In the case of human papillomavirus (HPV), two high-risk HPV oncogenes, E6 and E7, bind to TP53/p53 and RB1/pRb, thereby inactivating them and contributing to the development of cervical cancer and head and neck squamous cell carcinomas (HNSCCs). This evidence concerns the gene TP53 and cervical cancer.